Beyond the Apnea–Hypopnea Index: Circulating Biomarkers and Device-Based Metrics for Cardiometabolic Risk Stratification in Obstructive Sleep Apnea
Journal of Clinical Medicine · 10.05.2026 · 15 (10) · 3668
DOI: 10.3390/jcm15103668 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.05.2026. Verfasst von Dumitru Cătălin Sârbu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology Clinic, Mureș County Clinical Hospital, 540011 Târgu Mureș, Romania. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FOCUS: Training and Guidance for UMFST Researchers in Health, European Union.
Abstract (Originalsprache)
Obstructive sleep apnea (OSA) is increasingly recognized not merely as a localized anatomical airway disorder, but as a complex systemic condition. While the apnea–hypopnea index (AHI) remains the traditional standard for diagnosis, it possesses inherent limitations in adequately predicting downstream adverse outcomes, necessitating the adoption of novel, comprehensive markers for refined risk stratification. This narrative review summarizes recent evidence on circulating biomarkers and device-based metrics that may complement the AHI for risk stratification in OSA. Beyond traditional metrics, emerging biomarkers in obstructive sleep apnea offer a multifaceted view of the disease, utilizing inflammatory, vascular, metabolic and novel molecular indicators to enhance clinical characterization. These biomarkers reflect key pathophysiological mechanisms, including systemic inflammation, endothelial dysfunction, metabolic imbalance and altered gut microbiota. Commonly studied markers show associations with disease severity and adverse health outcomes. In addition, novel molecular markers, such as microRNAs and advances in sleep study metrics, provide further insight into disease burden, prognosis and cardiovascular comorbidities. A multidimensional framework integrating accessible laboratory markers with device-based metrics may improve identification of patients with OSA who are at highest risk for cardiovascular and metabolic complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pulmonology Clinic, Mureș County Clinical Hospital, 540011 Târgu Mureș, Romania.
- Pulmonology Department, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540139 Târgu Mures, Romania.
- Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, 540139 Târgu Mureș, Romania.
ORCID-Profile: Dumitru Cătălin Sârbu, Mara Andreea Vultur, Maria Beatrice Ianoși, Dragoș Huțanu, Edith Simona Ianoși
Förderung
- FOCUS: Training and Guidance for UMFST Researchers in Health
- European Union
Zitieren
APA
Sârbu, D. C., Vultur, M. A., Ianoși, M. B., Sárközi, H. K., Huțanu, D., & Ianoși, E. S. (2026). Beyond the Apnea–Hypopnea Index: Circulating Biomarkers and Device-Based Metrics for Cardiometabolic Risk Stratification in Obstructive Sleep Apnea. Journal of Clinical Medicine, 15(10), 3668. https://doi.org/10.3390/jcm15103668
Vancouver
Sârbu DC, Vultur MA, Ianoși MB, Sárközi HK, Huțanu D, Ianoși ES. Beyond the Apnea–Hypopnea Index: Circulating Biomarkers and Device-Based Metrics for Cardiometabolic Risk Stratification in Obstructive Sleep Apnea. Journal of Clinical Medicine. 2026;15(10):3668. doi:10.3390/jcm15103668
BibTeX
@article{Srbu2026,
author = {Sârbu, Dumitru Cătălin and Vultur, Mara Andreea and Ianoși, Maria Beatrice and Sárközi, Hédi-Katalin and Huțanu, Dragoș and Ianoși, Edith Simona},
title = {Beyond the Apnea–Hypopnea Index: Circulating Biomarkers and Device-Based Metrics for Cardiometabolic Risk Stratification in Obstructive Sleep Apnea},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {10},
pages = {3668},
doi = {10.3390/jcm15103668}
}
EUVIMED